Published in Pediatr Infect Dis J on October 01, 2002
Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department | NCT00867789
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol (2006) 5.97
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest (2009) 3.24
Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol (2004) 2.47
Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis (2009) 2.31
Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol (2004) 2.17
Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol (2006) 1.81
The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus. Infect Immun (2008) 1.77
contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis (2009) 1.74
Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia. J Clin Microbiol (2010) 1.73
Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol (2006) 1.71
Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada. J Clin Microbiol (2005) 1.70
Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother (2005) 1.65
Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol (2007) 1.62
Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother (2005) 1.33
Development of a vaccine against Staphylococcus aureus. Semin Immunopathol (2011) 1.32
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis (2013) 1.32
Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis. PLoS One (2013) 1.26
Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates. J Clin Microbiol (2008) 1.26
Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis (2011) 1.26
Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp. J Clin Microbiol (2006) 1.24
Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles? PLoS One (2011) 1.21
Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization. J Clin Microbiol (2012) 1.20
Inducible Clindamycin Resistance among Staphylococci Isolated from Burn Patients. Libyan J Med (2009) 1.13
Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis (2005) 1.13
Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit. Eur J Pediatr (2006) 1.05
Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California. J Clin Microbiol (2007) 1.05
Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors. Curr Infect Dis Rep (2003) 0.96
High prevalence of ST121 in community-associated methicillin-susceptible Staphylococcus aureus lineages responsible for skin and soft tissue infections in Portuguese children. Eur J Clin Microbiol Infect Dis (2010) 0.96
Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated Staphylococci. Eur J Clin Microbiol Infect Dis (2008) 0.88
Adherence to CLSI recommendations for testing of Staphylococcus aureus isolates in Louisiana hospitals: report of a clinical failure and results of a questionnaire study. J Clin Microbiol (2011) 0.87
Blinded comparison of repetitive-sequence PCR and multilocus sequence typing for genotyping methicillin-resistant Staphylococcus aureus isolates from a children's hospital in St. Louis, Missouri. J Clin Microbiol (2006) 0.86
Epidemiologic Similarities in Pediatric Community-Associated Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus in the San Francisco Bay Area. J Pediatric Infect Dis Soc (2012) 0.84
A report on infection dynamics of inducible clindamycin resistance of Staphylococcus aureus isolated from a teaching hospital in India. Asian Pac J Trop Biomed (2013) 0.82
Risk factors for community-associated Staphylococcus aureus skin infection in children of Maui. Hawaii J Med Public Health (2012) 0.82
Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections. J Infect Public Health (2014) 0.81
A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can J Infect Dis Med Microbiol (2007) 0.81
New Staphylococcus aureus genotyping method based on exotoxin (set) genes. J Clin Microbiol (2006) 0.79
Management of pediatric skin abscesses in pediatric, general academic and community emergency departments. West J Emerg Med (2011) 0.79
Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997. J Clin Microbiol (2015) 0.79
Community associated MRSA: an alert to paediatricians. Arch Dis Child (2006) 0.78
Invasive community-acquired Staphylococcus aureus among pediatric population of Eastern Iran. Iran J Microbiol (2014) 0.78
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia. BMC Res Notes (2013) 0.76
Analysis of methicillin resistance among Staphylococcus aureus blood isolates in an emergency department. J Korean Med Sci (2007) 0.75
A sentinel fatal paediatric case of community-associated methicillin-resistant Staphylococcus aureus in Canada. Paediatr Child Health (2007) 0.75
Utilizing Pharmacy Records to Assess Antibiotic Prescribing Patterns on the Incidence of Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in Children. J Pediatr Pharmacol Ther (2007) 0.75
Community-Associated Methicillin-Resistant Staphylococcus aureus in the Pediatric Population. J Pediatr Pharmacol Ther (2008) 0.75
Staphylococcus aureus antimicrobial susceptibility of abscess samples from adults and children from the Kaleida Health System in western New York State, 2003 to 2006. J Clin Microbiol (2010) 0.75
Performance of an electronic health record-based phenotype algorithm to identify community associated methicillin-resistant Staphylococcus aureus cases and controls for genetic association studies. BMC Infect Dis (2016) 0.75
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
Practice guidelines for the management of bacterial meningitis. Clin Infect Dis (2004) 7.79
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71
The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 4.71
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis (2005) 4.16
Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J (2006) 4.00
Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis (2005) 3.91
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics (2004) 3.71
Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol (2007) 3.25
Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis (2005) 3.21
Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis (2011) 3.16
Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics (2005) 3.13
An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis (2002) 2.94
Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J (2004) 2.91
Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis (2008) 2.72
Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2005) 2.28
Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics (2006) 2.17
Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother (2002) 2.12
Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2006) 2.10
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2013) 1.90
Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J (2011) 1.86
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics (2010) 1.77
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J (2003) 1.76
Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J (2007) 1.65
Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J (2007) 1.65
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J (2006) 1.60
Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J (2010) 1.59
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother (2005) 1.57
Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J (2006) 1.57
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol (2009) 1.55
Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine (2010) 1.44
Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics (2006) 1.41
Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect (2012) 1.40
Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J (2004) 1.39
Hepatosplenic cat-scratch fever. Lancet Infect Dis (2008) 1.38
Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am (2009) 1.37
The changing face of pleural empyemas in children: epidemiology and management. Pediatrics (2004) 1.29
Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J (2002) 1.28
Multicenter surveillance of invasive meningococcal infections in children. Pediatrics (2006) 1.27
Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J (2005) 1.27
Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis (2003) 1.25
Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J (2002) 1.22
Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics (2008) 1.20
Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis (2003) 1.19
Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol (2009) 1.16
Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J (2003) 1.14
Streptococcus pneumoniae infections in the neonate. Pediatrics (2003) 1.14
Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J (2009) 1.14
Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics (2006) 1.13
Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J (2013) 1.13
Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol (2008) 1.12
Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol (2003) 1.12
Impact of the conjugate pneumococcal vaccine in arkansas. Pediatr Infect Dis J (2004) 1.10
Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J (2002) 1.09
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis (2007) 1.08
Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother (2011) 1.06
Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol (2010) 1.02
Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin Vaccine Immunol (2008) 1.01
Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr Infect Dis J (2011) 0.96
Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J (2010) 0.96
Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila) (2002) 0.95
Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol (2011) 0.95
Hematologic effects of linezolid in young children. Pediatr Infect Dis J (2003) 0.94
Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant (2007) 0.93
Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine (2005) 0.93
The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J (2012) 0.92
Cat-scratch disease occurring in three siblings simultaneously. Pediatr Infect Dis J (2003) 0.91
Toxocariasis causing eosinophilic ascites. Pediatr Infect Dis J (2008) 0.90